Cargando…
Whole‐blood dysregulation of actin‐cytoskeleton pathway in adult spinal muscular atrophy patients
OBJECTIVE: Recent advances in therapeutics have improved prognosis for severely affected spinal muscular atrophy (SMA) type 1 and 2 patients, while the best method of treatment for SMA type 3 patients with later onset of disease is unknown. To better characterize the SMA type 3 population and provid...
Autores principales: | Siranosian, Jennifer J., Nery, Flavia C., Alves, Christiano R. R., Siranosian, Benjamin A., Lyons, Nicholas J., Eichelberger, Eric J., Garner, Reid, Da Silva Duarte Lepez, Salomé, Johnstone, Alec J., Subramanian, Aravind, Swoboda, Kathryn J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359125/ https://www.ncbi.nlm.nih.gov/pubmed/32558393 http://dx.doi.org/10.1002/acn3.51092 |
Ejemplares similares
-
Whole blood survival motor neuron protein levels correlate with severity of denervation in spinal muscular atrophy
por: Alves, Christiano R. R., et al.
Publicado: (2020) -
Impaired kidney structure and function in spinal muscular atrophy
por: Nery, Flávia C., et al.
Publicado: (2019) -
Implications of circulating neurofilaments for spinal muscular atrophy treatment early in life: A case series
por: Alves, Christiano R.R., et al.
Publicado: (2021) -
Increased systemic HSP70B levels in spinal muscular atrophy infants
por: Eichelberger, Eric J., et al.
Publicado: (2021) -
A conversation with Dr. Brett Leav, Vice President of Clinical Development for Public Health Vaccines, Moderna
por: Siranosian, Kathy
Publicado: (2022)